Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers

PURPOSE: Administration of three doses of Pfizer-BioNTech BNT162b2 COVID-19 mRNA vaccine was completed in Japan in the spring of 2022. This study aimed to evaluate the antibody responses, and kinetics of three doses of vaccine in healthcare workers (HCWs). PATIENTS AND METHODS: We conducted a longit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Hidenori, Mukai, Junji, Kushibiki, Kenichi, Mizushima, Sayuri, Maeda, Kyoko, Fujimoto, Yuko, Sawada, Ryugo, Oda, Manabu, Okuda, Hiroshi, Yamaki, Mayumi, Hashiguchi, Shin, Kawai, Ichiro, Kawaguchi, Izumi, Masuda, Noriyuki, Matsushita, Haruhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684125/
https://www.ncbi.nlm.nih.gov/pubmed/36460533
http://dx.doi.org/10.1016/j.vaccine.2022.11.049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684125/
https://www.ncbi.nlm.nih.gov/pubmed/36460533
http://dx.doi.org/10.1016/j.vaccine.2022.11.049

Ejemplares similares